GEOVAX LABS INC

GeoVax Labs is a biotechnology company whose core business model involves animal testing for vaccine development. The company’s pipeline of vaccine candidates, including those for HIV, cancer, and infectious diseases, requires preclinical testing in animal models as a standard regulatory step. This reliance on animal experimentation places the company within the scope of commercial animal exploitation.

A November 2025 audit report on U.S. laboratories documented hundreds of animal welfare violations, evidencing widespread suffering in research facilities. While the report did not name GeoVax specifically, the company operates within this same research and development ecosystem where such systemic issues are prevalent. The absence of publicly available, detailed animal welfare policies or a commitment to alternative testing methods indicates the company’s operations are aligned with industry practices that exploit animals at scale.